Cargando…
Src-Family Protein Kinase Inhibitors Suppress MYB Activity in a p300-Dependent Manner
Recent studies have disclosed transcription factor MYB as a potential drug target for malignancies that are dependent on deregulated MYB function, including acute myeloid leukemia (AML) and adenoid cystic carcinoma (ACC). Although transcription factors are often regarded as undruggable, successful t...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997952/ https://www.ncbi.nlm.nih.gov/pubmed/35406726 http://dx.doi.org/10.3390/cells11071162 |